BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 29, 2008
View Archived Issues
Bisphosphonate-antibiotic combination compounds prevent osteomyelitis in vivo
Read More
Tremelimumab evaluated in melanoma and gastric and esophageal cancer patients
Read More
CYT-21304, a multifunctional nanotherapy improves tumor targeting of paclitaxel
Read More
FDA approves Biovail's NDA for Aplenzin once-daily for depression in adults
Read More
Shire acquires global rights to Metazym for metachromatic leukodystrophy from Zymenex
Read More
INCB-028060, a novel c-Met kinase inhibitor demonstrates benefits in cancer therapy
Read More
Palomid-529: A novel antiangiogenic, antitumor agent from Paloma Pharmaceuticals
Read More
Novel agents for arthritis and other inflammatory/autoimmune disorders revealed in recent patents
Read More
Wyeth withdraws application for extension to European marketing authorization for Tygacil
Read More
Arana and Kyowa Hakko sign agreement to codevelop ART-104 for colorectal cancer
Read More
Epix reports positive results from reread of images from phase III studies of Vasovist
Read More
Addex initiates phase I trial of two formulations of ADX-10059 for GERD
Read More
FDA grants permission to Stem Cell Therapeutics to initiate its phase IIb trial of NTx-265
Read More
Cara initiates phase I clinical trial for novel long-acting analgesic, CR-845
Read More
European Commission approves HIV protease inhibitor Aptivus
Read More
Swissmedic grants orphan drug status for CUV-1647 for erythropoietic porphyries
Read More
Acusphere submits NDA to FDA for the Imagify ultrasound imaging agent
Read More
New therapeutic options for HCV infection disclosed in recent GSK and Tibotec patents
Read More
E.U. approves Zevalin as first-line consolidation treatment
Read More
Recent Bayer patent divulges new compounds for renal disorders
Read More
Arrowhead subsidiaries Calando and Insert Therapeutics complete merger
Read More
Dyax and Cubist enter license agreement for development and commercialization of DX-88
Read More
Novartis applies for Japanese approval of vildagliptin in type 2 diabetes
Read More
FDA approves once-a-month dose of Actonel for postmenopausal osteoporosis
Read More
Astellas Pharma and CoMentis sign collaboration agreement for beta-secretase inhibitors
Read More
Nventa reports results from fourth cohort in phase I clinical trial of Hsp-E7 in CIN
Read More